…
Brenntag SE distributes chemicals and ingredients in Germany, the United States, the United Kingdom, China, Canada, Italy, Poland, France, and internationally. The company operates in two segments, Brenntag Essentials and Brenntag Specialties. It provides just-in-time delivery, product mixing, blending, repackaging, inventory management, and drum return handling, as well as application, marketing and supply chain solutions, technical and formulation support, comprehensive regulatory know-how, and digital solutions, such as digital sales channels and product platforms. The company serves customers in various industries, including nutrition, pharma, beauty and care, and water treatment; and industrial markets, as well as coatings, adhesives, sealants and elastomers, and constructions, polymers, and rubber industries. The company was founded in 1874 and is headquartered in Essen, Germany.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
Brenntag AG is a global distributor of industrial and specialty chemicals that provides logistics, blending and sales services to customers across end markets such as food, pharmaceuticals and water treatment. Long-term growth may be driven by rising demand for specialty formulations, expansion in emerging markets and greater penetration of value‑added and digital supply‑chain services, while scale and a diversified supplier network could support more resilient margins.
Major risks include commodity price swings and margin pressure from competitive distribution, regulatory and environmental compliance, and execution or leverage risks from acquisitions.
Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Income before tax | 485.22M | 742.60M | 1002.80M | 1234.90M | 650.30M |
| Minority interest | -5.10M | -7.50M | -7.20M | -15.70M | -13.10M |
| Net income | 264.50M | 536.20M | 714.90M | 886.80M | 448.30M |
| Selling general administrative | 630.70M | 332.40M | 290.60M | 183.80M | 111.30M |
| Selling and marketing expenses | - | 329.80M | 295.50M | 323.80M | 271.60M |
| Gross profit | 1959.77M | 4026.50M | 4020.10M | 4319.00M | 3379.00M |
| Reconciled depreciation | 589.30M | 444.10M | 422.40M | 406.40M | 373.50M |
| Ebit | 732.93M | 888.00M | 1118.10M | 1359.00M | 745.90M |
| Ebitda | 1155.47M | 1332.10M | 1506.10M | 1765.40M | 1119.40M |
| Depreciation and amortization | 422.54M | 444.10M | 388.00M | 406.40M | 373.50M |
| Operating income | 732.93M | 915.40M | 1122.70M | 1382.40M | 742.40M |
| Other operating expenses | 14432.89M | 15322.00M | 15692.40M | 18039.20M | 13636.80M |
| Interest expense | 137.65M | 142.14M | 108.00M | 101.10M | 62.00M |
| Tax provision | 215.70M | 198.90M | 251.20M | 332.40M | 188.90M |
| Interest income | 14.60M | 19.00M | 22.70M | 16.70M | 4.50M |
| Net interest income | -130.80M | -131.70M | -93.20M | -85.40M | -59.60M |
| Income tax expense | 215.62M | 198.90M | 281.70M | 332.40M | 188.90M |
| Total revenue | 15165.82M | 16237.40M | 16815.10M | 19429.30M | 14382.50M |
| Total operating expenses | 1226.84M | 3111.10M | 2897.40M | 2928.90M | 2633.30M |
| Cost of revenue | 13206.05M | 12210.90M | 12795.00M | 15110.30M | 11003.50M |
| Total other income expense net | -247.71M | -172.80M | -119.90M | -147.50M | -92.10M |
| Net income from continuing ops | 269.70M | 543.70M | 689.40M | 902.50M | 461.40M |
| Net income applicable to common shares | - | - | - | 886.80M | 448.30M |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Total assets | 10833.74M | 11668.00M | 10337.80M | 11373.00M | 10195.50M |
| Intangible assets | 509.11M | 598.80M | 362.20M | 347.80M | 370.70M |
| Other current assets | 213.32M | 445.50M | 387.80M | 16.20M | 13.70M |
| Total liab | 6486.77M | 6906.00M | 5981.10M | 6570.30M | 6200.20M |
| Total stockholder equity | 4312.48M | 4726.70M | 4304.70M | 4752.50M | 3914.20M |
| Other current liab | 693.04M | 969.10M | 1239.10M | 307.50M | 326.90M |
| Common stock | 144.35M | 144.40M | 147.50M | 154.50M | 154.50M |
| Capital stock | 144.40M | 144.40M | 147.50M | 154.50M | 154.50M |
| Retained earnings | 3643.63M | 3675.80M | 3419.00M | 3035.00M | 2283.30M |
| Other liab | - | - | - | 666.20M | 688.20M |
| Good will | 3155.92M | 3446.00M | 3210.80M | 3111.50M | 2988.10M |
| Other assets | - | - | -35.10M | 331.20M | 309.80M |
| Cash | 797.60M | 763.30M | 576.90M | 1046.10M | 705.00M |
| Total current liabilities | 2462.68M | 3478.20M | 3021.00M | 3238.00M | 3526.10M |
| Current deferred revenue | 32.99M | - | 4.40M | 729.30M | 1006.40M |
| Net debt | 2461.18M | 2612.60M | 1855.50M | 1881.80M | 1956.70M |
| Short term debt | 238.91M | 861.30M | 312.70M | 339.20M | 717.00M |
| Short long term debt | 117.80M | 724.40M | 155.60M | 229.20M | 605.30M |
| Short long term debt total | 3258.78M | 3375.90M | 2432.40M | 2927.90M | 2661.70M |
| Other stockholder equity | 754.92M | 755.20M | 738.20M | 1563.00M | 1476.40M |
| Property plant equipment | - | - | - | 1655.40M | 1563.00M |
| Total current assets | 4718.03M | 5088.90M | 4612.60M | 5920.30M | 4958.10M |
| Net tangible assets | - | - | - | 1293.20M | 555.40M |
| Short term investments | - | 7.20M | 8.40M | - | - |
| Net receivables | 2343.72M | 2361.70M | 2263.10M | 2676.80M | 2547.50M |
| Long term debt | 2600.80M | 2034.20M | 1792.70M | 2264.40M | 1610.80M |
| Inventory | 1363.39M | 1518.40M | 1376.40M | 1773.80M | 1621.90M |
| Accounts payable | 1497.74M | 1406.20M | 1368.00M | 1862.00M | 1475.80M |
| Accumulated other comprehensive income | -230.41M | 151.30M | -14.00M | - | - |
| Non currrent assets other | 27.49M | 87.40M | 355.10M | 70.50M | 74.70M |
| Non current assets total | 6115.71M | 6579.10M | 5725.20M | 5452.70M | 5237.40M |
| Capital lease obligations | 541.40M | 617.30M | 449.80M | 434.30M | 445.60M |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Investments | 0.90M | -749.00M | -489.50M | -401.40M | 2.50M |
| Change to liabilities | - | - | - | 15.20M | 412.20M |
| Total cashflows from investing activities | -410.05M | -749.00M | -558.30M | -401.40M | -608.50M |
| Net borrowings | -33.20M | 809.30M | -594.90M | 99.80M | 401.30M |
| Total cash from financing activities | -488.92M | 23.00M | -1553.80M | -225.80M | 174.10M |
| Change to operating activities | - | - | - | 30.10M | 450.30M |
| Net income | 264.50M | 543.70M | 721.10M | 902.50M | 461.40M |
| Change in cash | 125.08M | 186.40M | -469.20M | 341.10M | -21.30M |
| Begin period cash flow | 672.53M | 576.90M | 1046.10M | 705.00M | 726.30M |
| End period cash flow | 797.60M | 763.30M | 576.90M | 1046.10M | 705.00M |
| Total cash from operating activities | 966.34M | 906.60M | 1663.90M | 956.70M | 388.60M |
| Depreciation | 422.54M | 444.10M | 388.00M | 406.40M | 373.50M |
| Other cashflows from investing activities | - | 29.20M | 31.60M | - | - |
| Dividends paid | 303.09M | 303.20M | 304.70M | -224.00M | -208.60M |
| Change to inventory | 76.17M | -78.40M | 404.10M | -94.10M | -506.10M |
| Change to account receivables | 110.36M | 76.90M | 436.00M | -306.80M | -556.30M |
| Sale purchase of stock | 0.00M | -250.10M | -496.20M | - | - |
| Other cashflows from financing activities | -152.64M | -233.00M | -14.80M | -1.80M | 795.30M |
| Change to netincome | - | - | - | 57.90M | 235.10M |
| Capital expenditures | 292.89M | 342.20M | 321.10M | 267.20M | 199.30M |
| Change in working capital | 38.99M | -108.70M | 543.50M | -355.60M | -612.10M |
| Stock based compensation | - | - | 19.50M | - | - |
| Other non cash items | 207.82M | 27.50M | 11.30M | 3.40M | 165.80M |
| Free cash flow | 673.45M | 564.40M | 1342.80M | 689.50M | 189.30M |
Sector: Basic Materials Industry: Specialty Chemicals
|
Stock Name
|
Change
(USD) |
Price
(USD) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
Enterprise Value
to Revenue (x) |
Enterprise Value
to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| BNTGF Brenntag AG |
- -% |
64.81 | 23.55 | 10.96 | 0.66 | 1.94 | 0.59 | 6.99 |
| LIN Linde plc Ordinary Shares |
-0.49 0.10% |
508.16 | 33.77 | 28.90 | 6.56 | 5.42 | 7.03 | 18.92 |
| AIQUY Air Liquide SA ADR |
-0.04 0.10% |
38.86 | 30.69 | 24.81 | 4.70 | 4.10 | 4.36 | 15.61 |
| AIQUF L'Air Liquide S.A |
- -% |
193.33 | 29.78 | 22.68 | 4.54 | 3.98 | 4.50 | 15.90 |
| SHW Sherwin-Williams Co |
-5.21 1.60% |
320.80 | 33.33 | 27.40 | 3.38 | 20.60 | 3.88 | 21.36 |
Brenntag SE distributes chemicals and ingredients in Germany, the United States, the United Kingdom, China, Canada, Italy, Poland, France, and internationally. The company operates in two segments, Brenntag Essentials and Brenntag Specialties. It provides just-in-time delivery, product mixing, blending, repackaging, inventory management, and drum return handling, as well as application, marketing and supply chain solutions, technical and formulation support, comprehensive regulatory know-how, and digital solutions, such as digital sales channels and product platforms. The company serves customers in various industries, including nutrition, pharma, beauty and care, and water treatment; and industrial markets, as well as coatings, adhesives, sealants and elastomers, and constructions, polymers, and rubber industries. The company was founded in 1874 and is headquartered in Essen, Germany.
| Name | Title | Year Born |
|---|---|---|
| Dr. Christian Kohlpaintner | Chairman of the Management Board & CEO | 1963 |
| Mr. Henri Nejade | COO of Brenntag Specialties & Member of the Board of Management | 1962 |
| Mr. Steven H. J. Terwindt | COO of Brenntag Essentials & Member of the Management Board | 1967 |
| Mr. Ewout Van Jarwaarde | Chief Transformation Officer & Member of the Management Board | NA |
| Dr. Kristin Neumann | CFO & Member of the Management Board | 1972 |
| Mr. Thomas Altmann | Sr. VP of Investor Relations | NA |
| Ms. Marion J. G. Mestrom | Chief HR Officer | 1961 |
| Ms. Ursula Baumgartner-Durchschlag | Head of Laboratory & Qualified Person | NA |
| Mr. Jens Birgersson | Chairman of the Management Board & CEO | 1967 |
| Mr. Thomas Reisten | CFO & Member of the Management Board | 1972 |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.